Catalog No.
EVV25501
Expression system
Mammalian cells
Species
Junin mammarenavirus (JUNV) (Junn mammarenavirus)
Protein length
Glu59-Leu250
Predicted molecular weight
50.49 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P26313
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Pre-glycoprotein polyprotein GP complex, Glycoprotein G1, GP1, GPC, GP-C
A hTfR1 Receptor-Specific VHH Antibody Neutralizes Pseudoviruses Expressing Glycoproteins from Junín and Machupo Viruses. [EVV25501]
A New Vaccine Candidate Expressing JUNV GP1-GP2 Against Argentine Hemorrhagic Fever Based on Baculovirus Surface Display., PMID:40514553
A hTfR1 Receptor-Specific VHH Antibody Neutralizes Pseudoviruses Expressing Glycoproteins from Junín and Machupo Viruses., PMID:39772257
Cellular N-Myristoyl Transferases Are Required for Mammarenavirus Multiplication., PMID:39339839
Cellular N-myristoyl transferases Are Required for Mammarenavirus Multiplication., PMID:39211253
Glycoprotein-Specific Polyclonal Antibodies Targeting Machupo Virus Protect Guinea Pigs against Lethal Infection., PMID:38932403
VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein Display., PMID:36719225
Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies., PMID:35315691
Antibody-Based Inhibition of Pathogenic New World Hemorrhagic Fever Mammarenaviruses by Steric Occlusion of the Human Transferrin Receptor 1 Apical Domain., PMID:34132574
Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector., PMID:32111526
Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junín virus., PMID:31760108
Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein., PMID:30061671
Novel neutralizing monoclonal antibodies against Junin virus., PMID:29870772
Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses., PMID:29760382
Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization., PMID:28630325
Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses., PMID:28100617
Molecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses., PMID:26651946
Characterization of Junín virus particles inactivated by a zinc finger-reactive compound., PMID:19463727
Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: implications for receptor usage and pathogenicity., PMID:17397892
For research use only. Not for human or drug use.
